Abstract. Alkaloid contents in Argemone mexicana cell line AMMiF were analyzed during a 36-day culture cycle. The benzophenanthridine sanguinarine (SA) represented the main alkaloid. Dihydrosanguinarine (DHSA), a SA biosynthetic precursor and a less toxic benzophenanthridine, was also identified, based on chromatographic properties and further confirmed by gas chromatography coupled to mass spectrometry. Along the culture cycle, SA contents increased simultaneously while DHSA decrease, suggesting their biosynthetic conversion. Upon exposure to yeast extract as an inducer of secondary metabolism, there was an increase in SA content, which was preceded by DHS accumulation. However, after a long exposure (72 h), contents of both SA and DHSA were noticeable elevated, with close to 20% of the total alkaloid produced being recovered from the external medium. These results suggest the operation of a cell mechanism to avoid damage inflicted by the excessive accumulation of SA. Key words: Argemone mexicana, benzophenathridines, dihydrosanguinarine, sanguinarine.
Introduction
Argemone mexicana (L) (Papaveraceae) is a plant used in the Mexican traditional medicine. The healing properties of A. mexicana were presumably well known to ancient Mesoamerican cultures, prior to the arrival of Europeans [1] . The presence of a number of benzylisoquinoline alkaloids (BIA) may explain such medicinal effects. For example, the benzophenanthridines sanguinarine (SA) and dihydrosanguinarine (DHSA) display antimicrobiae and cytotoxic activities. These alkaloids are accumulated in roots and mature seeds, whereas berberine, a protoberberine alkaloid with antiviral properties, is accrued both in aerial and underground tissues [2] . The toxic nature of these compounds suggests an ecological role in the chemical defense against herbivores [3] . BIA's are formed from two units of tyrosine which after a series hydroxylation, deamination and decarboxylation reactions, are condensed into norcoclaurine. Further enzymatic reactions transform this intermediary into the benzophenanthridines alkaloids [4] . In accordance to their protective role, the biosynthesis of BIA's is transcriptionally activated in response to environmental injury and this has been applied with biotechnological purposes to increase alkaloid production in in vitro cell cultures [5] . These cultures exposed to conditions mimicking a pathogenic attack increase SA biosynthesis and some portion of it is excreted to the external medium [6] . Furthermore, part of this newly synthesized SA is reduced to the less toxic DHSA suggesting the operation of an enzymatic detoxification mechanism [6, 7] . We have an A. mexicana cell suspension culture, namely AMMiF, which produces significant amounts of SA and DHSA, even without any induction treatment [7] . Interestingly, SA accumulation increased when DHSA decreased, implying the conversion of one into the other. Upon induction with yeast extract, the accumulation of both SA and DHSA increased, although in a limited fashion in comparison to cultures of other SA producing species [7] and also following different patterns, which may point to the operation of a cellular mechanism to avoid damage from an excessive accumulation of SA.
Results
Alkaloids were extracted from A. mexicana cell suspensions and analyzed by TLC. Under UV long wavelength light (365 nm), SA was identified by its red-orange fluorescence at Rf 0.70, identical to the standard. A second red-orange fluorescent spot at Rf 0.89 was also recorded (Fig. 1) . Fluorescence properties suggest that this compound was a benzophenanthridine.
Besides SA, other benzophenantrhridines have been identified in A. mexicana tissues, mainly DHSA, chelerythrine, dihydrochelerythrine and chelidoline [2] . In order to assign an identity to this unknown compound, extracts were analyzed by GC-MS. (8); 290 (46), was similar to the standard and as has been previously reported [9] . Therefore, based on MS data, and the well known metabolic interconversion between SA and DHSA [6] , the unknown benzophenanthridine was identified as DHSA.
Along the first phase of a culture cycle, DHSA contents decreased while those of SA steadily increased to a maximum, nearing to 14 nmol g DW -1 . Interestingly, maximal SA content was attained simultaneously to DHSA lowest contents (near to 6 nmol g DW -1 ; Fig. 2) . SA is the result of DHSA oxidation; hence, these results indicate that the biosynthetic pathway leading to sanguinarine formation is fully active in the AMMiF cell line.
In order to induce alkaloid accumulation, Argemone cell suspensions were exposed to yeast extract (200 mg L -1 ). This dose probed to be the most effective [8] . Prior to cell exposure, SA was the prominent alkaloid with little DHSA found. During the first 24 h of exposure, DHSA content increased markedly (from 0.7 to 32 nmol g DW -1 ; i.e a 42-fold increase), whereas the initial SA contents only increased around 2.5-fold (from 7 to 19 nmol g DW -1 ). However, after 48 h DHSA returned to its initial values, while SA amounts remained at a similar level, and after 72 h, both SA and DHSA presented similar amounts. It is noteworthy to mention that a significant amount of SA was recovered from the spent medium, but no DHSA was detected (Table 1) .
Discussion
Successful plant chemical defense requires a delicate balance involving production of noxious compounds in amounts enough to repel herbivore or pathogen attack while preventing their toxic effects in the cells that produces or accumulates them. Through the course of evolution, different mechanisms have developed to achieve this goal, including the sequestering of toxic compounds in vesicles, their chemical modification to less toxic forms, readily reconverted to the more active forms when required, and their excretion [10] . SA displays a cationic nature which allows it to bind to the negatively charged membranes and proteins, interfering with their functioning. The reduction of SA to its dihydro form diminishes these effects, resulting in a less toxic compound [6] . The first response to YE elicitation of the Argemone AMMiF cell line involved a pronounced accumulation of DHSA, with little effect on SA levels (Table 1) . Since DHSA is the precursor of SA in the biosynthetic pathway (Fig. 1) , this result suggests, that at these early phases of induction, DHSA concentration in the cell built up prior its oxidation to SA. As the response progressed, DHSA was transformed into SA, which then was apparently excreted (Table 1 ; 48 h), preventing in this way its possible toxic effects. At longer periods, when the maximal response was reached (Table 1 ; 72 h), it appeared that either the rate of DHSA oxidation to SA decreased, or that SA was reduced back to DHSA (Fig. 1) . Interestingly, only SA, but not DHSA, was recovered from the medium, and in substantially lesser amounts than those extracted from the cell package (Table 1) . In an alternative manner, SA could also have been degraded. Chromatographic analysis revealed the presence of putative benzophenanthridines, which could not be identified due to their unstable nature. The formation of these unstable, short-lived, products has been previously observed [6] . Finally, such response suggests the operation of a mechanism to cope with the deleterious effects of SA inside the cell [7] , which involves the control of the internal amounts of the oxidized form by reducing it to DHSA, and/or excreting it to the external medium.
Conclusion
In A. mexicana cell suspension cultures, the toxic effects of a high benzophenanthridine accumulation, induced by YE, are managed through reducing the internal contents of the oxidized (SA) to the less toxic dihydro (DHSA) forms or its excretion to the medium.
Experimental section
Biological materials. The Argemone mexicana cell line AMMiF has been maintained through biweekly subcultures in PC-BN medium (inorganic salts and vitamins of Phillips and Collins medium, supplemented with 0.5 and 1.5 mg L -1 of benzyladenine and naphtalenacetic acid, respectively and 20 g L -1 of sucrose [8] . Analytical procedures. Alkaloids were extracted from freeze dried tissues with HCl 0.5% in methanol (v/v). Between 100 and 150 mg of ground tissues were incubated at 45 °C with gently shaking for 2 h. Cell debris was removed by filtration and the acidic extract was reduced to dryness at low pressure. Residue was dissolved in 1 mL of methanol and alkaloids were separated by thin layer chromatography (TLC), using as mobile phase a benzene/ethanol (9/1 by vol.) mixture. SA and DHSA were quantified by in situ fluorescence (325 and 545 nm for excitation and emission, respectively) using a Shimadzu CS-930 dual wavelength chromatoscanner, equipped with a DR 2 data collector (Kyoto Japan). Alkaloid identity was assigned based on Rf's values, and further confirmed by gas chromatography coupled to mass spectroscopy (GC-MS). GC-MS was carried out in an Agilent Technologies 6890N gas chromatographer coupled to a 5975B mass detector, using a glass capillary column (25 m × 0.32 mm i.d × 30 µm). Nitrogen was used as carrier gas at a flow rate of 45 mL min -1 . Injector and detector temperatures were set at 150 and 300 °C, respectively. Initial column temperature was 80 °C, then increased to 300 °C (2 min), and finally kept at 300 °C (10 min). Alkaloids were identified comparing fragmentation patterns to those previously reported [9] . 
